Cargando…

Macrophages promote polycystic kidney disease progression

Renal M2-like macrophages have critical roles in tissue repair stimulating tubule cell proliferation and, if they remain, fibrosis. M2-like macrophages have also been implicated in promoting cyst expansion in mouse models of autosomal dominant polycystic kidney disease (ADPKD). While renal macrophag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swenson-Fields, Katherine I., Vivian, Carolyn J., Salah, Sally M., Peda, Jacqueline D., Davis, Bradley M., van Rooijen, Nico, Wallace, Darren P., Fields, Timothy A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028685/ https://www.ncbi.nlm.nih.gov/pubmed/23423256 http://dx.doi.org/10.1038/ki.2012.446

Ejemplares similares

Autocrine IL-10 activation of the STAT3 pathway is required for pathological macrophage differentiation in polycystic kidney disease
por: Peda, Jacqueline D., et al.
Publicado: (2016)

Caspase-1 and the inflammasome promote polycystic kidney disease progression
por: Swenson-Fields, Katherine I., et al.
Publicado: (2022)

The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease
por: Jamadar, Abeda, et al.
Publicado: (2021)

Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells
por: Silva, Luciane M., et al.
Publicado: (2018)

Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease
por: Wallace, Darren P., et al.
Publicado: (2013)

Quinomycin A reduces cyst progression in polycystic kidney disease
por: Radadiya, Priyanka S., et al.
Publicado: (2021)

Effects of Ischemia on Lung Macrophages
por: Moldobaeva, Aigul, et al.
Publicado: (2011)

microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism
por: Hajarnis, Sachin, et al.
Publicado: (2017)

PKD1 and PKD2 mRNA cis-inhibition drives polycystic kidney disease progression
por: Lakhia, Ronak, et al.
Publicado: (2022)

Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease
por: Sweeney, William E, et al.
Publicado: (2017)

The Role of Phospholipase D in Modulating the MTOR Signaling Pathway in Polycystic Kidney Disease
por: Liu, Yang, et al.
Publicado: (2013)

Is polycystic kidney disease associated with malignancy in children?
por: Friend, Brian D., et al.
Publicado: (2019)

Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney Disease
por: Idowu, Jessica, et al.
Publicado: (2018)

Renal disease progression in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2012)

Immune checkpoint activity regulates polycystic kidney disease progression
por: Kleczko, Emily K., et al.
Publicado: (2023)

Polycystic horseshoe kidney
por: Prasad, A. K., et al.
Publicado: (2013)

Growth in Children with Autosomal Recessive Polycystic Kidney Disease in the CKiD Cohort Study
por: Hartung, Erum A., et al.
Publicado: (2016)

CaMK4 overexpression in polycystic kidney disease promotes mTOR-mediated cell proliferation
por: Zhang, Yan, et al.
Publicado: (2022)

Prediction of Progression in Polycystic Kidney Disease Using the Kidney Failure Risk Equation and Ultrasound Parameters
por: Akbari, Ayub, et al.
Publicado: (2020)

Weight loss and cystic disease progression in autosomal dominant polycystic kidney disease
por: Hopp, Katharina, et al.
Publicado: (2021)

Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease
por: Radadiya, Priyanka S., et al.
Publicado: (2021)

Empirically Evaluated Suicide Prevention Program Approaches for Older Adults: A Systematic Review
por: Miller, Vivian, et al.
Publicado: (2021)

Empirically Evaluated Suicide Prevention Program Approaches for Older Adults: A Systematic Review
por: Miller, Vivian, et al.
Publicado: (2021)

Standardizing total kidney volume measurements for clinical trials of autosomal dominant polycystic kidney disease
por: Edwards, Marie E, et al.
Publicado: (2018)

The Expanding Role of MT1-MMP in Cancer Progression
por: Knapinska, Anna M., et al.
Publicado: (2019)

Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease
por: Riwanto, Meliana, et al.
Publicado: (2016)

Horseshoe polycystic kidney
por: Maple, Hannah, et al.
Publicado: (2013)

Polycystic horseshoe kidney
por: Ram, Rapur, et al.
Publicado: (2013)

CD8(+) T cells modulate autosomal dominant polycystic kidney disease progression
por: Kleczko, Emily K., et al.
Publicado: (2018)

Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease
por: Tangri, Navdeep, et al.
Publicado: (2017)

Kidney and cystic volume imaging for disease presentation and progression in the cat autosomal dominant polycystic kidney disease large animal model
por: Yu, Yoshihiko, et al.
Publicado: (2019)

Systems biology approach to identify transcriptome reprogramming and candidate microRNA targets during the progression of polycystic kidney disease
por: Pandey, Priyanka, et al.
Publicado: (2011)

Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies
por: Nowak, Kristen L., et al.
Publicado: (2021)

Molecular genetic analysis of polycystic kidney disease 1 and polycystic kidney disease 2 mutations in pedigrees with autosomal dominant polycystic kidney disease
por: Bitarafan, Fatemeh, et al.
Publicado: (2019)

Global Gene Expression Profiling in PPAR-γ Agonist-Treated Kidneys in an Orthologous Rat Model of Human Autosomal Recessive Polycystic Kidney Disease
por: Yoshihara, Daisuke, et al.
Publicado: (2012)

The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease
por: Sundar, Shirin V., et al.
Publicado: (2022)

Automatic semantic segmentation of kidney cysts in MR images of patients affected by autosomal-dominant polycystic kidney disease
por: Kline, Timothy L., et al.
Publicado: (2020)

Autosomal Recessive Polycystic Kidney Disease
por: Hafer, Ashley S., et al.
Publicado: (2017)

Nonselective Cyclooxygenase Inhibition Retards Cyst Progression in a Murine Model of Autosomal Dominant Polycystic Kidney Disease
por: Zhang, Min, et al.
Publicado: (2019)

Gene expression in early and progression phases of autosomal dominant polycystic kidney disease
por: Chen, Wen-Cheng, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_iej0r0qdufib6n7e8te8bnnm91